Akebia Therapeutics
Development and commercialization of therapeutics for patients with chronic kidney disease. Learn more
Launch date
Employees
Market cap
€275m
Enterprise valuation
€284m (Public information from Sep 2024)
Share price
$1.37 AKBA
Cambridge Massachusetts (HQ)
Authorizing premium user...